Clinical Submission Deadline for Pharmaceutical Manufacturers

The Alaska Department of Health, Division of Health Care Services, has announced a public meeting of the Pharmacy and Therapeutics Committee scheduled for November 20, 2026, at 8:00 a.m. The meeting will be conducted exclusively via teleconference and webinar to address the state's Preferred Drug List (PDL). Pharmaceutical manufacturers and the public are invited to submit materials for consideration. Manufacturers must submit clinical information by November 6, 2026, while general public and healthcare professional submissions are due by November 18, 2026. All submissions must include a conflict of interest disclosure form. Public comment opportunities are available during the meeting, with specific protocols for industry representatives and healthcare professionals. Industry presentations are limited to three minutes and must comply with federal regulations, with potential misrepresentations reported to the FDA's Office of Prescription Drug Promotion. The meeting will be recorded, and special accommodations for individuals with disabilities must be requested by November 18, 2026.